Patients with chronic heart failure (CHF) have significantly reduced the plasma levels of RvD1 and pretreatment of mononuclear cells of patients with CHF with RvD1 or RvD2, which did not affect cytokine release from CD8+ and CD4+ T cells. This evidence concerns the gene CD8A and congestive heart failure.